These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4935908)

  • 1. The relationship between lesion site, dopamine neurons, and turning behavior in the rat.
    Crow TJ
    Exp Neurol; 1971 Aug; 32(2):247-55. PubMed ID: 4935908
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase relationships support a role for coordinated activity in the indirect pathway in organizing slow oscillations in basal ganglia output after loss of dopamine.
    Walters JR; Hu D; Itoga CA; Parr-Brownlie LC; Bergstrom DA
    Neuroscience; 2007 Jan; 144(2):762-76. PubMed ID: 17112675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nigral lesion on chlorpromazine-induced acceleration of dopamine synthesis from [14C]tyrosine.
    Nybäck H; Sedvall C
    J Pharm Pharmacol; 1971 May; 23(5):322-6. PubMed ID: 4397399
    [No Abstract]   [Full Text] [Related]  

  • 6. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT; Fibiger HC
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract]   [Full Text] [Related]  

  • 7. Axoplasmic transport of dopamine in nigro-striatal neurons.
    Fibiger HC; McGeer EG; Atmadja S
    J Neurochem; 1973 Aug; 21(2):373-85. PubMed ID: 4125072
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of a unilateral stereotaxic injection of Tinuvin 123 into the substantia nigra on the nigrostriatal dopaminergic pathway in the rat.
    Jackson-Lewis V; Liberatore G
    Brain Res; 2000 Jun; 866(1-2):197-210. PubMed ID: 10825495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible dopaminergic pathway from substantia nigra to putamen.
    York DH
    Brain Res; 1970 Jun; 20(2):233-49. PubMed ID: 4396620
    [No Abstract]   [Full Text] [Related]  

  • 10. Complex functions of basal ganglia.
    Teuber HL
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():151-68. PubMed ID: 826995
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo continuous estimation of 3 H-dopamine synthesis and release in the cat caudate nucleus. Effects of -methyl-p-tyrosine and of transection of the nigro neostriatal pathway.
    Besson MJ; Cheramy A; Gauchy C; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):101-5. PubMed ID: 4267960
    [No Abstract]   [Full Text] [Related]  

  • 12. Turning behavior induced by electrical stimulation of the nigro-neostriatal system of the rat.
    Arbuthnott GW; Ungerstedt U
    Exp Neurol; 1975 Apr; 47(1):162-72. PubMed ID: 164362
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
    Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain.
    Bruggeman R; Westerink BH; Timmerman W
    Eur J Pharmacol; 1997 Apr; 324(1):49-56. PubMed ID: 9137912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The substantia nigra and stereotyped behaviour.
    Costall B; Naylor RJ; Olley JE
    Eur J Pharmacol; 1972 Apr; 18(1):95-106. PubMed ID: 4555563
    [No Abstract]   [Full Text] [Related]  

  • 16. Dissociation of morphine-induced potentiation of turning and striatal dopamine release by amphetamine in the nigrally-lesioned rat.
    Kimmel HL; Justice JB; Holtzman SG
    Eur J Pharmacol; 1998 Apr; 346(2-3):203-8. PubMed ID: 9652361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-DOPA and reserpine: effects on evoked potentials in basal ganglia of freely moving rats.
    Dafny N; Gilman S
    Brain Res; 1973 Feb; 50(1):187-91. PubMed ID: 4690546
    [No Abstract]   [Full Text] [Related]  

  • 18. Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat.
    Moore AE; Cicchetti F; Hennen J; Isacson O
    Exp Neurol; 2001 Dec; 172(2):363-76. PubMed ID: 11716560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quetiapine increases the firing rate of rat substantia nigra and ventral tegmental area dopamine neurons in vitro.
    Werkman TR; Olijslagers JE; Perlstein B; Jansen AH; McCreary AC; Kruse CG; Wadman WJ
    Eur J Pharmacol; 2004 Dec; 506(1):47-53. PubMed ID: 15588623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia nigra compacta neurons that innervate the reticular thalamic nucleus in the rat also project to striatum or globus pallidus: implications for abnormal motor behavior.
    Anaya-Martinez V; Martinez-Marcos A; Martinez-Fong D; Aceves J; Erlij D
    Neuroscience; 2006 Dec; 143(2):477-86. PubMed ID: 17008017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.